Literature DB >> 22718760

Targeted depletion of TDP-43 expression in the spinal cord motor neurons leads to the development of amyotrophic lateral sclerosis-like phenotypes in mice.

Lien-Szu Wu1, Wei-Cheng Cheng, C-K James Shen.   

Abstract

ALS, or amyotrophic lateral sclerosis, is a progressive and fatal motor neuron disease with no effective medicine. Importantly, the majority of the ALS cases are with TDP-43 proteinopathies characterized with TDP-43-positive, ubiquitin-positive inclusions (UBIs) in the cytosol. However, the role of the mismetabolism of TDP-43 in the pathogenesis of ALS with TDP-43 proteinopathies is unclear. Using the conditional mouse gene targeting approach, we show that mice with inactivation of the Tardbp gene in the spinal cord motor neurons (HB9:Cre-Tardbp(lx/-)) exhibit progressive and male-dominant development of ALS-related phenotypes including kyphosis, motor dysfunctions, muscle weakness/atrophy, motor neuron loss, and astrocytosis in the spinal cord. Significantly, ubiquitinated proteins accumulate in the TDP-43-depleted motor neurons of the spinal cords of HB9:Cre-Tardbp(lx/-) mice with the ALS phenotypes. This study not only establishes an important role of TDP-43 in the long term survival and functioning of the mammalian spinal cord motor neurons, but also establishes that loss of TDP-43 function could be one major cause for neurodegeneration in ALS with TDP-43 proteinopathies.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22718760      PMCID: PMC3431639          DOI: 10.1074/jbc.M112.359000

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  58 in total

1.  Reduction of axonal caliber does not alleviate motor neuron disease caused by mutant superoxide dismutase 1.

Authors:  M D Nguyen; R C Larivière; J P Julien
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

2.  Patterning of muscle acetylcholine receptor gene expression in the absence of motor innervation.

Authors:  X Yang; S Arber; C William; L Li; Y Tanabe; T M Jessell; C Birchmeier; S J Burden
Journal:  Neuron       Date:  2001-05       Impact factor: 17.173

3.  Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

Authors:  Manuela Neumann; Deepak M Sampathu; Linda K Kwong; Adam C Truax; Matthew C Micsenyi; Thomas T Chou; Jennifer Bruce; Theresa Schuck; Murray Grossman; Christopher M Clark; Leo F McCluskey; Bruce L Miller; Eliezer Masliah; Ian R Mackenzie; Howard Feldman; Wolfgang Feiden; Hans A Kretzschmar; John Q Trojanowski; Virginia M-Y Lee
Journal:  Science       Date:  2006-10-06       Impact factor: 47.728

Review 4.  Opinion: What is the role of protein aggregation in neurodegeneration?

Authors:  Christopher A Ross; Michelle A Poirier
Journal:  Nat Rev Mol Cell Biol       Date:  2005-11       Impact factor: 94.444

Review 5.  Molecular biology of amyotrophic lateral sclerosis: insights from genetics.

Authors:  Piera Pasinelli; Robert H Brown
Journal:  Nat Rev Neurosci       Date:  2006-09       Impact factor: 34.870

6.  Cooperation between GDNF/Ret and ephrinA/EphA4 signals for motor-axon pathway selection in the limb.

Authors:  Edgar R Kramer; Laura Knott; Fengyun Su; Eric Dessaud; Catherine E Krull; Françoise Helmbacher; Rüdiger Klein
Journal:  Neuron       Date:  2006-04-06       Impact factor: 17.173

7.  Requirement for the homeobox gene Hb9 in the consolidation of motor neuron identity.

Authors:  S Arber; B Han; M Mendelsohn; M Smith; T M Jessell; S Sockanathan
Journal:  Neuron       Date:  1999-08       Impact factor: 17.173

Review 8.  Molecular and cellular pathways of neurodegeneration in motor neurone disease.

Authors:  P J Shaw
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-08       Impact factor: 10.154

9.  Redox system expression in the motor neurons in amyotrophic lateral sclerosis (ALS): immunohistochemical studies on sporadic ALS, superoxide dismutase 1 (SOD1)-mutated familial ALS, and SOD1-mutated ALS animal models.

Authors:  Shinsuke Kato; Masako Kato; Yasuko Abe; Tomohiro Matsumura; Takeshi Nishino; Masashi Aoki; Yasuto Itoyama; Kohtaro Asayama; Akira Awaya; Asao Hirano; Eisaku Ohama
Journal:  Acta Neuropathol       Date:  2005-06-28       Impact factor: 17.088

10.  Structural diversity and functional implications of the eukaryotic TDP gene family.

Authors:  Hurng-Yi Wang; I-Fan Wang; Jayaramakrishnan Bose; C-K James Shen
Journal:  Genomics       Date:  2004-01       Impact factor: 5.736

View more
  81 in total

Review 1.  Amyotrophic lateral sclerosis: an update on recent genetic insights.

Authors:  Yohei Iguchi; Masahisa Katsuno; Kensuke Ikenaka; Shinsuke Ishigaki; Gen Sobue
Journal:  J Neurol       Date:  2013-10-02       Impact factor: 4.849

2.  Familial Amyotrophic Lateral Sclerosis-linked Mutations in Profilin 1 Exacerbate TDP-43-induced Degeneration in the Retina of Drosophila melanogaster through an Increase in the Cytoplasmic Localization of TDP-43.

Authors:  Koji Matsukawa; Tadafumi Hashimoto; Taisei Matsumoto; Ryoko Ihara; Takahiro Chihara; Masayuki Miura; Tomoko Wakabayashi; Takeshi Iwatsubo
Journal:  J Biol Chem       Date:  2016-09-15       Impact factor: 5.157

Review 3.  Emerging mechanisms of molecular pathology in ALS.

Authors:  Owen M Peters; Mehdi Ghasemi; Robert H Brown
Journal:  J Clin Invest       Date:  2015-05-01       Impact factor: 14.808

Review 4.  Biology and Pathobiology of TDP-43 and Emergent Therapeutic Strategies.

Authors:  Lin Guo; James Shorter
Journal:  Cold Spring Harb Perspect Med       Date:  2017-09-01       Impact factor: 6.915

5.  Protein-RNA Networks Regulated by Normal and ALS-Associated Mutant HNRNPA2B1 in the Nervous System.

Authors:  Fernando J Martinez; Gabriel A Pratt; Eric L Van Nostrand; Ranjan Batra; Stephanie C Huelga; Katannya Kapeli; Peter Freese; Seung J Chun; Karen Ling; Chelsea Gelboin-Burkhart; Layla Fijany; Harrison C Wang; Julia K Nussbacher; Sara M Broski; Hong Joo Kim; Rea Lardelli; Balaji Sundararaman; John P Donohue; Ashkan Javaherian; Jens Lykke-Andersen; Steven Finkbeiner; C Frank Bennett; Manuel Ares; Christopher B Burge; J Paul Taylor; Frank Rigo; Gene W Yeo
Journal:  Neuron       Date:  2016-10-20       Impact factor: 17.173

6.  Cell-autonomous requirement of TDP-43, an ALS/FTD signature protein, for oligodendrocyte survival and myelination.

Authors:  Jia Wang; Wan Yun Ho; Kenneth Lim; Jia Feng; Greg Tucker-Kellogg; Klaus-Armin Nave; Shuo-Chien Ling
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-29       Impact factor: 11.205

Review 7.  TDP43 and RNA instability in amyotrophic lateral sclerosis.

Authors:  Kaitlin Weskamp; Sami J Barmada
Journal:  Brain Res       Date:  2018-01-31       Impact factor: 3.252

Review 8.  TDP-43/FUS in motor neuron disease: Complexity and challenges.

Authors:  Erika N Guerrero; Haibo Wang; Joy Mitra; Pavana M Hegde; Sara E Stowell; Nicole F Liachko; Brian C Kraemer; Ralph M Garruto; K S Rao; Muralidhar L Hegde
Journal:  Prog Neurobiol       Date:  2016-09-28       Impact factor: 11.685

9.  Loss of ALS-associated TDP-43 in zebrafish causes muscle degeneration, vascular dysfunction, and reduced motor neuron axon outgrowth.

Authors:  Bettina Schmid; Alexander Hruscha; Sebastian Hogl; Julia Banzhaf-Strathmann; Katrin Strecker; Julie van der Zee; Mathias Teucke; Stefan Eimer; Jan Hegermann; Maike Kittelmann; Elisabeth Kremmer; Marc Cruts; Barbara Solchenberger; Laura Hasenkamp; Frauke van Bebber; Christine Van Broeckhoven; Dieter Edbauer; Stefan F Lichtenthaler; Christian Haass
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-01       Impact factor: 11.205

10.  Expression of ALS-linked TDP-43 mutant in astrocytes causes non-cell-autonomous motor neuron death in rats.

Authors:  Jianbin Tong; Cao Huang; Fangfang Bi; Qinxue Wu; Bo Huang; Xionghao Liu; Fang Li; Hongxia Zhou; Xu-Gang Xia
Journal:  EMBO J       Date:  2013-05-28       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.